Technical Application of YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol in Research

What This Product Solves

YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol (SKU B7641) is a crystalline small molecule designed for research workflows investigating hypoxia-inducible signaling and vascular biology. Its dual function as an sGC activator and post-transcriptional HIF-1α inhibitor supports studies on inhibition of hypoxia-inducible factor 1 transcriptional activity, tumor angiogenesis inhibition, and apoptosis and cancer biology research. Because it is soluble in DMSO and ethanol and supplied at high purity (>98%), YC-1 enables consistent dosing in cell-based assays and in vivo models. Experiments commonly use YC-1 to:

• Probe HIF-1α regulatory mechanisms in hypoxic tumor microenvironments
• Assess the impact of sGC activation on platelet aggregation and vascular contraction
• Evaluate anti-angiogenic strategies in cancer research

YC-1 is not intended for clinical or diagnostic applications, and its mechanistic actions should be interpreted in the context of controlled laboratory research. For a deeper discussion of the molecular mechanisms and evidence-based experimental design with YC-1, see "YC-1: Unveiling New Frontiers in Hypoxia, cGMP, and Cancer Biology"—this article links the compound’s dual activity to workflows in cancer and hypoxia research. Additionally, "Advancing Cell-Based Assays with YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol" provides validated protocol guidance and troubleshooting for cell-based applications.

Protocol Parameters

• solubility in DMSO | ≥30.4 mg/mL | stock preparation for cell-based or in vivo assays | Ensures high-concentration stock solutions for accurate dosing; avoid water due to insolubility | product_spec [product_url]
• solubility in ethanol | ≥16.2 mg/mL | alternative stock preparation | Provides flexibility for ethanol-compatible protocols; supports workflows sensitive to DMSO | product_spec [product_url]
• storage conditions | room temperature (solid), avoid long-term storage of solutions | stock integrity and reproducibility | Stability of solid form at ambient temperature; DMSO or ethanol solutions should be freshly prepared | product_spec [product_url]
• working concentration (cell assays) | 1–50 μM (recommendation) | initial titration in apoptosis and cancer biology research | Start with a broad range to determine IC50/EC50 relevant to the chosen model; adjust based on cell sensitivity and endpoint | workflow_recommendation

Workflow Setup and QC Checklist

1. Preparation of Stock Solutions: Dissolve YC-1 in DMSO (preferred) or ethanol at the specified solubility limits. Mix until fully dissolved; filter sterilize if required by your protocol. Avoid water as a solvent due to insolubility.
2. Storage: Keep solid YC-1 at room temperature, protected from light and moisture. Prepare fresh solutions before each use to minimize compound degradation.
3. Aliquoting and Handling: Dispense aliquots to minimize freeze-thaw cycles. Use appropriate personal protective equipment and work in a chemical fume hood when handling solvents.
4. Quality Control: Confirm solution clarity and absence of precipitate before application. If using in cell culture, pre-warm solutions to avoid temperature-induced precipitation.
5. Documentation: Record batch numbers, preparation date, and concentrations for traceability. Note any deviations from recommended protocols.

Common Failure Modes and Fixes

• Precipitation in Solution: YC-1 is insoluble in water and may precipitate if added directly. Fix: Always dissolve first in DMSO or ethanol at the recommended concentration, then dilute into aqueous media with vigorous mixing.
• Loss of Activity Over Time: Extended storage of YC-1 in solution can lead to degradation. Fix: Prepare fresh working solutions before each experiment and avoid storing diluted stocks for more than one day.
• Batch-to-Batch Variability: Inconsistent results may stem from differences in stock preparation or compound handling. Fix: Standardize protocols, document handling steps, and use the same batch for parallel experiments when possible.

Scope and Limitations

YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is validated for research workflows involving mechanistic studies of HIF-1α inhibition, tumor angiogenesis inhibition, and cGMP pathway modulation. It is not formulated for, nor should it be used in, diagnostic, medical, or clinical studies. Mechanistic claims regarding apoptosis, anti-angiogenic effects, or anticancer efficacy should be restricted to well-controlled laboratory systems. Quantitative outcomes, IC50/EC50 values, or in vivo dosing regimens must be determined empirically for each application and are not provided in the product dossier.

Conclusion

YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol offers researchers a reliable tool for dissecting hypoxia, vascular, and tumor biology pathways. By following the solubility, storage, and workflow precautions outlined in the product documentation and above, users can maximize reproducibility and data quality. For further details on validated use cases and technical insights, refer to the APExBIO product page: YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol.